Expert Urges FDA to Pull Diabetes Drug from Market

An FDA scientist has recommended the diabetes drug Avandia be pulled from the market for heightening heart attack risks associated with its use. Dr. David Graham made the recommendation during a meeting of a scientific advisory panel which will consider whether the drug should continue to carry FDA approval, according to the Associated Press. In May, a study published in the New England Journal of Medicine called attention to heart problems associated with the drug.

read in full

Questions Remain on Bush Changes to the Regulatory Process

As of July 24, agencies are to be in full compliance with President Bush's recent changes to the regulatory process. But the American people remain in the dark in knowing how these changes will influence the way our government operates. A new analysis by OMB Watch reiterates our concerns with the changes, identifies the many questions that remain, and describes Congress's efforts to mitigate their impact through oversight hearings and proposed legislation. Read the analysis: E.O. 13422: Unanswered and Unaccountable

read in full

Another Risk to Consumer Safety

As we blogged earlier this month, the Consumer Product Safety Commission (CPSC) has been without a quorum since July 2006. This has prevented it from fully addressing all of its responsibilities since January of this year. The agency oversees the safety of thousands of domestic and foreign consumer goods used in homes, schools, and sports.

read in full

Paranoia Strikes Deep

The Associated Press (AP) published a story today noting the decline in the U.S. Environmental Protection Agency's (EPA) criminal enforcement of polluters. According to the article, "The number of the Environmental Protection Agency's criminal investigators has dropped this year to 174, below the 200-agent minimum required by Congress, even as the EPA's overall criminal enforcement budget rose nearly 25 percent over three years to $48 million, according to EPA records." Civil settlements, however, which require spending on pollution controls, are increasing.

read in full

Progress in the FDA? Think again.

You'd think that U.S. Food and Drug Administration (FDA) officials would be willing to listen to their own employees as public confidence in the agency diminishes among a string of regulatory lapses and congressional investigations. However, a BNA report ($) suggests otherwise.

read in full

Victims of High Dioxin Exposure Levels Left Behind

Residents of Mossville, LA, have three times the level of dioxin in their blood as the national average, and 90 percent of the residents have illnesses that are linked to dioxin exposure. These are conclusions drawn from government data, so the humane, responsible thing for government agencies to do is — nothing.

read in full

Fish and Wildlife Reviewing MacDonald's Interference

The U.S. Fish and Wildlife Service announced recently that it planned to review eight Endangered Species Act (ESA) decisions ex-deputy assistant secretary Julie MacDonald influenced according to a BNA story (subscription) published yesterday. FWS has identified eight among hundreds its reviewed that MacDonald may have influenced for political considerations.

read in full

FEMA Ignores Toxic Trailers of Hurricane Victims

The Federal Emergency Management Agency (FEMA) turned a blind eye to Katrina victims who became ill while living in FEMA-provided trailers, according to testimony given at a hearing of the House Committee on Oversight and Government Reform on July 19. Trailer tenants and experts described how FEMA, with evidence of toxic levels of formaldehyde in the trailers from construction materials, refused to substantively evaluate the extent of the problem, respond to known instances of formaldehyde poisoning or take adequate precautionary action.

read in full

Surgeon General Warning: Manipulated Science

At a July 10 hearing of the House Committee on Oversight and Government Reform, former Bush administration Surgeon General Richard Carmona joined a growing list of officials to disclose the executive branch's political manipulation of science. Carmona's claims that agency science is being distorted for political purposes echoes charges leveled by recent whistleblowers from the Department of the Interior, the U.S. Food and Drug Administration, the U.S. Environmental Protection Agency (EPA) and the National Aeronautics and Space Administration.

read in full

White House Delays Whale Protection Rule

The White House is currently delaying the completion of a final rule intended to protect a critically endangered whale species. Critics are concerned the Bush administration is giving special access to business interests and overemphasizing economic considerations in its review of the rule. The delay of the whale protection rule is indicative of a larger problem in the White House regulatory review process.

read in full

Pages